1. Fresenius Medical
Fresenius Medical Care AG & Co.KGaA is one of the three branches of the Fresenius Group and a world leader in dialysis products and services, with 90,690 employees. The company serves 270,000 patients worldwide through its 3,250 dialysis centers throughout the United States, Europe, Latin America and Asia Pacific. The company first established the standard production specifications for dialyzers in 1983 and has since dominated the development of global artificial kidney (dialysis) products.
According to the company's annual report, in 2013, Fresenius medical revenue reached US$14.6 billion and its gross profit margin was 32.4%. The North American market has a 66% market share and the Asia Pacific region accounts for only 7%. Divided by income composition, the company's dialysis products revenue was 3.48 billion US dollars, and dialysis service income was 11.13 billion US dollars.
.jpg)
2. Jinbao
Gambro is a global medical technology company focused on the development, production and manufacture of products for acute and chronic kidney and liver dialysis, myeloma and renal therapy and other in vitro therapeutic products. The company was founded in 1964 in Rand, Sweden. The founder is Holger Crafoord, an industrialist who is determined to develop and provide one of the world's first human kidneys. He currently has 8,000 employees and 13 production sites in 9 countries. Available in more than 100 countries. On July 22, 2013, Gambro was acquired by Baxter International for $40.
Baxter
Baxter International (NYSE: BAX) was founded in 1931 with 48,500 employees worldwide and production facilities in 27 countries. Baxter is a diversified multinational medical products company with two major business segments: bioscience and medical products . Baxter launched peritoneal dialysis products and treatments 30 years ago. It is the world's leading manufacturer in this field, accounting for about 80% of the global market share. Prior to the acquisition of Swedish Campbell's hemodialysis business, it was the third largest provider of hemodialysis products in the world.
.jpg)
According to the company's annual report, in 2013, Baxter International's operating income was US$15.259 billion, of which medical sector revenue was US$8.695 billion, and renal dialysis (including blood and peritoneal dialysis) business (Renal) revenue was US$3.089 billion.
Baxter's US and European operating income totaled US$11.1 billion, accounting for 73% of total operating revenue. Baxter's Asia Pacific revenues were $2.4 billion, accounting for 16%.
.jpg)
Food Additive Corngerm Cake,Corn Gluten Meal Augustine,Pets Corn Gluten Meal,Corn Gluten Meal Weed Killer
JILIN COFCO BIO-CHEM AND BIO-ENERGY MARKETING CO., LTD , https://www.cofco-biotech.com